Profiles
Peptides A to Z
26 profiles, from AOD-9604 to Tirzepatide. Each one opens with where the peptide stands with the FDA today, then gets into the research.
Status checked November 2, 2026
Peptides, checked against the record.
Where each peptide stands with the FDA today, and what the studies behind it found. We link the record for every claim, and we sell nothing.
Regulation
Who may make it, and who may not
Why a pharmacy may make some peptides and not others. A "research use only" label does not change the answer.
Guides
Reading a peptide study
Start by telling a rat study from a human trial. It changes how you read every profile on this site.
Also on this site
Most read
- SemaglutideApproved for type 2 diabetes, weight, heart risk and MASH liver diseaseFDA approved
- TirzepatideApproved for type 2 diabetes, weight and sleep apneaFDA approved
- BPC-157Studied for gut, tendon and other tissue injury, mostly in ratsNot approved
- RetatrutideStudied for obesity, type 2 diabetes, knee osteoarthritis pain and sleep apneaNot approved
- TB-500 and Thymosin Beta-4Studied for eye, skin and IV use of full-length thymosin beta-4; TB-500 itself has no human studiesNot approved
- IpamorelinStudied for bowel recovery after surgeryNot approved
- CJC-1295Studied for growth hormone levels, in small trials in healthy adultsNot approved
- GHK-CuStudied for skin ulcers and laser-treated skin, as a topicalNot approved
One table for every peptide's status
Six questions for every peptide, from FDA approval to the WADA list. Each cell links to the record we read, and each row says when we last read it. You can also download it as a CSV.
Living+ Peptides is an education site run by Living+. We cite government records and published research, never sellers, and we make no treatment claims for unapproved peptides. When we get something wrong, the fix goes in the corrections log. More in the editorial policy and sources policy.